MEDIUM confidence: 100% data completeness, but the composite (58) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-08-09.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider $50K over 180 days (1 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 3.1%/yr (revenue basis).
Base free cash flow $374M (avg FY2023–FY2025; latest year $439M) · equity value $9.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.2B— | $2.8B-11.8% | $4.5B+59.5% | $5.2B+15.0% | $5.4B+4.7% |
| EPS (dil.) | $0.85— | $0.97+14.1% | $1.02+5.2% | $1.23+20.6% | $0.93-24.4% |
| Free Cash Flow | $296M— | $326M+10.1% | $342M+4.9% | $341M-0.3% | $439M+28.9% |
| Gross Margin | 15.5% | 20.3%+4.8pp | 16.0%-4.3pp | 16.7%+0.6pp | 17.7%+1.0pp |
| Operating Margin | 8.7% | 12.0%+3.3pp | 7.9%-4.1pp | 9.6%+1.7pp | 11.1%+1.5pp |
| Net Margin | 7.2% | 9.3%+2.0pp | 6.0%-3.2pp | 6.4%+0.4pp | 4.6%-1.9pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 63% → 63% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $0.40 | $0.42 | +5.9% |
| Apr 2026 | $0.31 | $0.34 | +9.7% |
| Jan 2026 | $0.31 | $0.35 | +12.9% |
| Nov 2025 | $0.40 | $0.45 | +11.6% |
| Jul 2025 | $0.37 | $0.43 | +16.2% |
| May 2025 | $0.30 | $0.33 | +9.4% |
| Jan 2025 | $0.34 | $0.35 | +2.9% |
| Nov 2024 | $0.37 | $0.35 | -5.4% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
TTEK's QScore of 58 indicates a moderately attractive stock, driven by its strong momentum and lower risk profile. The stock scores high on momentum, with a 12-month return of 21.4% and a bullish 50-day versus 200-day moving average trend. In contrast, its growth score is weighed down by a decline in EPS growth, despite positive revenue and free cash flow growth. The long-term and short-term scores are relatively aligned, with the short-term score slightly higher at 61, suggesting that recent trends are somewhat more favorable.